Neoadjuvant FOLFIRINOX for Borderline Resectable Pancreas Cancer: A New Treatment Paradigm?Kathleen K. Christians, Ben George, Huamin Wang et al.|The Oncologist|2014Cited by 191
Patency Rates of Portal Vein/Superior Mesenteric Vein Reconstruction After Pancreatectomy for Pancreatic CancerAshley N. Krepline, Susan Tsai, Kathleen K. Christians et al.|Journal of Gastrointestinal Surgery|2014Cited by 51
Neoadjuvant therapy for pancreatic cancer in patients older than age 75.John T. Miura, Susan Tsai, Ashley N. Krepline et al.|Journal of Clinical Oncology|2014Cited by 11
Association of decline in serum Ca19-9 after neoadjuvant therapy with improved survival among borderline resectable pancreatic cancer patients.Susan Tsai, Kathleen K. Christians, Ben George et al.|Journal of Clinical Oncology|2013Cited by 3